Taichi Kuramochi

This inventor holds 30 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 18 EPO patents, primarily in Antibody Engineering. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taichi Kuramochi. Retrieved from https://idiyas.com/inventor/taichi-kuramochi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 19)

% Patents Active = 93.3

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 18 (Patent Applications = 31)

Average Co-Inventor Count = 5.3

ph-index = 15

Forward Citations = 448(Granted Patents)

Location History:

Singapore, SG (2018 - 2022)
Shizuoka, JP (2013 - 2023)

Company Filing History:

30 out of 985

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Antibody Variants

Fc Region Modification

Therapeutic Agents

Cytotoxicity Induction

Antigen-Binding Molecules

Isoelectric Point Modification

Polypeptides

Plasma Retention

Humanized Antibodies

Cancer Therapeutics

Nucleic Acids

Improved Kinetics

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703738 - ANTIBODY CONSTANT REGION VARIANT (2026-08-11),

2. 12522669 - CYTOTOXICITY-INDUCING THERAPEUTIC AGENT (2026-01-13),

3. 12522648 - ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED FC REGION (2026-01-13),

4. 12479929 - ANTIBODIES WITH MUTATED HEAVY CHAIN CONSTANT REGIONS (2025-11-25),

5. 12371511 - Heterodimerized polypeptide (2025-07-29),

6. 12269876 - Modified Fc region of antibody (2025-04-08),

7. 12122840 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2024-10-22),

8. 12116414 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2024-10-15),

9. 11851476 - Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain (2023-12-26),

10. 11718678 - Method for altering plasma retention and immunogenicity of antigen-binding molecule (2023-08-08),

11. 11454633 - Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use (2022-09-27),

12. 11359009 - Anti-myostatin antibodies and methods of use (2022-06-14),

13. 11248053 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2022-02-15),

14. 11142563 - Antigen-binding molecule containing modified Fc region (2021-10-12),

15. 11066483 - Cytotoxicity-inducing therapeutic agent (2021-07-20),

Title: The Innovative Journey of Taichi Kuramochi

Introduction:

Taichi Kuramochi, a visionary inventor hailing from Shizuoka, Japan, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Taichi Kuramochi's latest patents include cutting-edge advancements in robotics, artificial intelligence, and sustainable energy solutions, showcasing his commitment to creating a more efficient and sustainable future.

Career Highlights:

With a career spanning over two decades, Taichi Kuramochi has established himself as a leading figure in the tech industry. His work has revolutionized various sectors, from healthcare to transportation, earning him recognition for his ingenuity and forward-thinking approach.

Collaborations:

Throughout his career, Taichi Kuramochi has collaborated with top research institutions, universities, and leading tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the development of innovative solutions with real-world applications.

Conclusion:

In conclusion, Taichi Kuramochi's passion for innovation and his relentless drive to push the boundaries of technology have solidified his reputation as a pioneering inventor. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.